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leaflets (46 vs, 20%, p = 0.C0"~) and moderate or severe mdral regurgitation 
(52 vs, 32%, p = 0,001 ) with :~ut significant age or sex differences, 
Conclusions' TVP in ass¢ clarion with MVP is infrequent, even in a referral 
population, and presents in patients with more severe myxomatous valve 
disease~ 
11:45 
~-3~ Enhen~KI Vls,,,sllutlon of Intrnvsscular Thrombus 
~ With t~lS U~!~- O? S Thrombus Targeting UltrHound 
Contrast Agsnt (MRX408): Evldenco From In Vivo 
Exl~r lmental  E,' .hO¢lrdlographk: StudkHI 
M, Takouchi, T,P M¢Creary, E Avetar, M Sheahan, R, Connolly, 
A, Santanen. E Ung~r, N, Pandian, Tufts- New England Medcal Center, 
~ton ,  Mass, USA 
Background: Detection of intr~so~tar thrembu~ (IVT) is not always easy 
by COnventional ul~rase~nd in~tgmg, We explored the potential of a new 
contrast agent t~rgetedto throm~rs (MRX408) using a I@d synthesized with 
a fargetiog mo~ety that is an RG3 analog in the evaluation of in v~o Iv'r. 
Methods: We moated intravascu!ar thrombus (Iv'r) by inserting thrombin 
soaked cotton threads into the infenor vena cava (IVC) in 9 dogs, With a 
Commercially available 2-D ech¢cardiographic System, we recorded images 
of the IVC at baseline w~th no ¢t,ntrast agent, during COntinuous infusion of 
MRXlt3 (a nontargetedcontrast agent as a Control) and intusmn o1 targeted 
agent, MRX408 Videointensity (VI, unitless) and the size of IVT (area) were 
analyzed blindly, Presence 0t IVT was venfied by autopsy. 
Results: In all instances of IVT, eff¢lent binding by the agent MRX408 and 
visually apparent increase in ultrasound contrast enhancement were noted. 
Vl o11VT was not different betwee't baseline and MRX113 (40.0 ± 14.6 and 
73.9 ± 41.3, p = ns) but was hKjher dunng MRX408 infusion (105.7 ± 47.8, p 
< 0.05 vs. Baseline and vs MRX113). The maximum area of IVT was similar 
dunng baseline and MRX 113 (p = ns) but was found to be target dunng 
MRX408 thfusion by >41 ± 9%and >34 ± 14%, (P < 0.01 for each). 
Conclus~n: The tissue targeted contrast agent, MRX408 enhances the 
wsualtzation of IVC thrombus It has the potential to improve the diagnostic 
power for detecting and delineating intravascular thrombus, even when a 
conventional ultrasound imaging medaflty is employed. 
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~ US/International Muit icenter Trial of Atrial Septal 
Catheter Closure Using the Amplatzer Septal 
Occluder: Initial Results 
J. Masura, PE  Lango, J.L Wilkinson, HH Kramer, M. Alwi. Y. Goussous. 
B. Thanopul0s, K.P. Walsh, Z.M HijaZL FOr the Aroplatzer Investigators, 
The Children's University Hospital, Bratislava, Sfovek Republic and 
Tutts-New England Medical Center, Boston, MA, USA 
From 9/95-8/'97, 229 patients with secunduro atrial septal defect, 11 with 
patent foramen ovale and associated stroke and 3 with tenestrated Fortran 
undenNent ranscatheter closure using the new self-centering, repositionable 
Amplatzer" Septal Occluder (ASO) at a median age of 6.6 yr (0.9-70 yr) and 
median weight of 22 kg (6.5-120 kg). The median size 0t the defect by 2D 
TEE was 12 rom (2-23 mm) and the median balloon stretched diameter was 
15 mm (3-26 ram). The median size o1 the device (size of COnnecting waist 
beh,,,een the h'~o disks) used to close the detect was 15 mm (4-26 ram). In lew 
patients, both disks of the device were inadvertently opened either in the left 
or right atrium, because of the ability of repositioning the de~ce, eventually 
all patients had correct device deployment. The median fluoroscopy time 
was 16 min, (2.3-64 rain.) and median total procedure time was 90 rain, 
(27-139 rain.). Complications included were 2 device embolization to the 
RV with successful catheter etrieval and 1 endocarditis necessitating device 
removal and I with transient ischemic attack. At 24 hours by color Doppler, 
74% of patients had complete (C) closure, 15% had trivial residual shunt 
(TS) and 6% had small residual shunt (SS). At one month follow-up by color 
Doppler, 91% of patients had C and 4.6% had TS and 2.8% had SS. No 
episodes of wire fracture or disruption. We conclude that the new ASO is 
safe and effective in completely closing most alrial communications. 
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8~- -~ Simu.l.tan_eoualy Implanted "Cr l socrou lng"  Slants 
PrOVlOe Excel lent Relief for Postoperat ive Bilateral 
Proximal Pulmonary ArIew Stenosmu With Closely 
Related ear ls  
T,M Zeltors, C,E, Mullins, M.R, Nthllt, RG, Gnfka, F,F Ing, gaYlOr College at 
Medicine and Tex~s Chil~en~ Hospital, ~n ,  T~, USA 
Background: For patents with Postoperative pt.t!nlorlary artery =!lenoses, ex- 
pandable intrevascu!ar slant placement is the treatment of choice. However, 
patients with postoperative t:dlatoml proximal pulm0nary artery ~efloses 
(PBPP$), with Closely related branch ost~, present a spec~l problem as 
proximal stent implantation rttRy compromise acces~ to the eontralateral ~d- 
mona~ adery. We hypothesized that simullanoousty implanted cnsscmssing 
stents (SIXS) woutd be sate. wotdd improve bemodynamcca and allow future 
as;ass to both pulmonary arteries, 
MethO0~: Twenty patients (15 M; 69 ~ 6.9 yo; 5.6 ~ 4.2 y post.as) with 
PBPPS, with (n .. 9) and witho~ MPA stenosis, had SIXS between 1993 
and 1997. The pnoclpal dmgnoses were dTGA (5), TOF (7), PA.VSD (41, 
Tmnctls (2) and AS/Ross procedure (1), We examined the change in RV:FA 
ratios, PA size and gradients, and branch sng!e wffh SIXS, 
RasfJffp: Hemodynamtca nd vessel size improved significantly with SIXS 
(table), but branch angles were not stgniftcantly changed, 
Rali~ Grad,'ents (P~nHg) Vessel size (ram] 
RVFA MPA-LPA MPA-RPA MPA LPA RPA 
Pre~tem 073:021 416~281 445":288 142±63 59-*20 67¢2.0 
Post-slant 039¢0.12 94_.71 99¢81 19;2¢38 133~2S 131z24 
Conclu~ons: SIXS provides excellem relief for pesloperatzve PBPPS 
white maintaining access tO both PAs and should be considered an excellent 
treatment choice for this problem. 
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~ Applicalion of Endovas©ular Stents on  the 
Management of Right Ventricular to Pulmonary 
Artery Conduit Stenosls 
C OvaerL CA. Catdarone. B.W. McCnndte, D. Nykanen. RM Freedom. 
LN. Benson. The Hospital for Stck Children, Unwersdy of Toronto, Toronto, 
Canada 
Background; Extracardiac conduits between the RV and pulmonary artenes 
commit patlents to multiple reoperations. Endovascular stenting of a stenot¢ 
conduit may delay reoporation. 
Methods; From 7/90 to 5/97. 42 patients underwent transcatheter stent 
insedion to relieve RV conduit stenosis Median age at procedure was 5.9 yrs 
(range, 6 me-17 yrs). with a median inten/al from conduit insertion of 24 ym 
(3 mo-13.9 yr'3). Clinical, echo, hemodynareic, ang~ographic and follow-up 
data were obtained. 
Results: RV systolic pressures decreased from 71 ± 18 mmHg to 48 ± 
15 mmHg (p = 0.0001) after slant placement, with an increase in the minimal 
diameter of the COnduit of 51 ± 44% (p = 0,0001), No major complications 
occurred. Eleven pts had 1 and 2 pts had 2 additional tronscathetar interven- 
tions to fudhcr dilate the slant or add an additional slant, Surgcal conduit 
replacement was required in 17 pts at a mean of 20 • 16 me after the slant 
placement. Of those without surgery, 12 pts have been followed <1 y. the 
remainder UP to 5.4 yrs with 1 late death at 2.8 yrs after stent placement. 
Freedom from surgical intervention was 62% at I yr, 66% at 2 yr and 39% 
at 3 yr after stenting There was no effect on freedom from surgery of pt age 
or duration of conduit at stenting, but higher initial RV pressures predicted 
decreased palliation, with a trend towards improved eady results in the 2nd 
half of the study. 
Conclusions: Transcatheter placement of endovsscular stents tn stenotic 
RV conduits significantly delays conduit replacement. 
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[-804--0"4~-4 Management of Pulmonary Artery Trauma due to 
L /  
Bal loon Dilation 
C.M. Baker, F.X. McGowan. JE  Lock, J.F. Kea=o. The Children's Hospital. 
Boston, Massachusetts, USA 
Background: Balloon dilation (BD) of the pulmonary artery (PA) is important m 
the management of peripheral pulmonary stenosis. Successful BD requires 
a controlled tear of the PA, however complications ranging from small pseu- 
doaneurysrns to PA rupture can occur. We report our expenence managing 
BD associated PA rupture. 
Methods: All records (1983-1997) for patients undergoing cardiac catheter- 
ization during which BD of a PA was performed were re,.-ewed using a corn- 
5~A AI{S'II,tACI'S Oral .IACC F~:hntar~ 19¢.),~ 
putorized database and defined criteria Cases with potential PA rupture were 
reviewed In detail Patients with only pulmonary edema or psoudoaneurysms 
without oxtravasation o! dye or blood wore excluded, 
Rosuffs: 1304 catheteriznliona that tncktdcd BD of tire PAs wore per- 
termed over 14 year period at out institution, PA rt0pt~.~ro was ldonttltod by 
frank hemoptyaia and/or nnglogrophlc oxtravasntlon in 22 (1.7%) catheteri- 
zations in 2f patients (ago 5 month~--41 yonrs), 
Medical management Is summarized in the tuttnwlng table: 
Th~r~npy CPn INO lX TX ,0,511V EINT 
~1 et PI~ ;t1~2 6/22 171~2 6122 7t22 
CPR ~, cnrdiopulmonnly re~uecllnt~nn, INO - inntrnp¢ nuppott, TX ~ trnn~fuelnn, BV = 
blend volume, EINT = ~lfllOfflt~at Illttlt)tltion 
Five patients died, Throe died from nn~ontrotlablo pulmonary hemorrhage; 
two the day of catheterization, and one 7 dny~ later, Two pnttont~ who had 
balloon tnmponnde of the rt~plurod PA died; one at tire tlm~ of BD, and one 
2 day~ po~f cnthntonzntlon, niter ~urvlving n prolonged resuscitation and 
~urglcnt repair, In four patients the deranged PA was ~uccesslully oocludod 
with cafheter.deployod ptoel coils,, nil survived, 
Cencfl~sten: PallenI~ wllh PA ruptnm nt~eciatod with ~3D may require 
tltfOllBIvo medical mnnsgoment, however, nddlttonnl ntanagomont ~tratogios 
am nocossnry to prevent mortality, Coil occlusion of Ibo damaged PA ~s a 
uselt~l technique for mnnagnment at PA trauma duo to BD nnd may provenl 
fatal hemorrhage 
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~4~ 18-Year Experience With Transseptal Procedures 
- - -  Through Baffles, Conduits and Other intra-atrlsl 
Patches 
H,G El,Said, F,F, Ing, M,R, Nil;ill, R,G, Grilka, C, Morns, $, Beck, 
13. Goffy.Hou,'~owright t,,~ Dyer, C E, Mnllins #'~d~atnc Card~olO.ClV, To~'~ 
Cltildron~ Hospit#l,£~avIor College Of It,fod~cmt~. HoltsfOr~, Tox,l,,$. USA 
Backgm~md: Tire presence of an lntra-atrial pnfcl~ ~IAP) has been considered 
a relative contm~ndication to transseptal puncture (TSP). The purpose at th~s 
study is to determine tl~o efficacy and safety of TSP tl~mugh baffles, conduits, 
pericardial patellas and other prosthetic materials in the 1airs-atrial septum 
Methods: RoeoKts el ~11 podiatric pati~,nfs wi!h t~P who undonNent TSP 
in Texas Children's Hospital from November 1979 through July 1997 were 
reviewed, including indications, technical difficulties and ochocardiograms 
specifically addressing ¢osidual leaks. 
Result,~ In over 2000 TSP portormod urm q tllis penod. 37 patients had an 
lAP Cardiac diagnoses included d-transL~osthon ftile groat arteries following 
Mustard (7) or Sen=ling procedure (6), single ventricle vanant post-Fonfan 
operation (2), total anomalous venous return repair (4), atriovontricular canal 
=epa, (9!. an~.f at.a~ septat detect wltl~ patch repair (9), Pahonts' age ranged 
from 1 to 43 years (moan ago 7 years). The duration from the time of surgical 
repair to TSP ranged from 0 t to 21 years {moan age 5 years!. Indications ot 
TSP included putmonaq/vein evaluation with balloon dilation an@'or stenting 
{ 10), fenestration ottllo atrial baffle (1), prosthetic mitral valve evaluation (1), 
and avoidance of tomoral artery trauma (14). The lAP was traversed in 3&~37 
patients t97%), followed by diagnostic and, or therapeutic prograde loll-heart 
catheterization, No complications were encountered No residual shunting 
was prosent by follow up echocardiography, except in one case in which the 
Fontan ballle was intentionally ienestrated 
Conclt~s~on. Transsoptal puncture through an intra-atrial patch is sate, 
This technique is effeehve in permitting diagnostic and therapeutic left heart 
catheterizatzon and does not result in residual shunhng through the patch 
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La04~_j Catheter-based Pharmacomechanlcal Treatment  of 
Major Thromboembol l sm In Infants and Chi ldren 
J J  Rome. A Rob "~so ~ k id Brtdges. KE  Fellows Ch~ldrens Hospital of 
Philadelphia, Philadelphia, PA. USA 
Background The optimal therapy for major thromboemboembolism (TE~ [n 
cL:ldhood ~s unknown TE are rare b J: often hfe-threafgnmg i.1 pediatrics We 
report our expenence with pharmacomechanica) treatment ~PMT) for TE =n 
children. 
Met%'Yis: Patients w~th emodynam=cah~, significant TE were candidates 
for PMT, Catheter access was obtained tallowed by Clot maceration with 
wires ancLor balloon angtoplasty. D=rect pulse-spray infusion of urokinase 
Luk: 4400 Ukg), followed by continuous infusion for 48 h was performed 
when not contra=ndlcated ~5 6~. 
Resrrlts Six patients underv,,ent PMT Two were neonates wdhout con- 
genital heart d~sease tCHD'~: one w=th saddle pulmonary, embolus (PE~ was 
profoundly hypo'~emic and one wtlh aortic tllfombo=us had pulse~ess lower 
extremities and acidosis. Fo~.=r patients (4-13 y) had CHD: 2 with PE (both 
after Fontan), and 2 with innominato vein thrembus (one post Fonfan and 
end post transplant), Clots completely resolved In 4 patients while vessel 
potency was reestablished with pomlstent clot in 2. Clinical Improvement 
associated witi~ clot lysts in neonates included resolution of hypoxomia (I/1) 
and normalization of extremity perfuslon (1/1), In CHD patients effusions 
resolved In 2/2, and central venous pressure normalized in 1/3, The neonate 
with saddle PE had evidence of Infroventrlcutar hemorrhage within 48 hm. 
Tills Infant was the only patient in the series not treated with uk. At fotlowup 
3 m to 3 y, no p~llont has hr~d symptomatic recurrence, 
Concltlston: PMT Is a safe and effective moons of treating mater throm- 
botic events in Infants and children, 
Cardiac Transplantation: Basic Science 
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[ 8.0§-~ Small Platslct Thrombl Contribute to Neolnt lmal 
......... Formation In AIIograft Vascular Disease by Bridging 
the inflammatory and Smooth Muscle Cell 
Responses 
L H. Chow, J, Jiang, R, Zhong, J,G, Pckonng Roberts Research Institute, 
Lonaon, Onhlno, Can~lc/~! 
Platelet thmmbi contribute signiliciantly to plaque progression in typical ath- 
emsclomsis, but little is known of their rote in allograft vascular disoas(~ To 
study the latter, wo histologically examined mouse aodie allograffs (C57BLJ6 
[H-2t'l to BALB/c [H-2"]) during oady noointimal formation (days 1-24) 
Mixed cellular advontitial inflammation at day 5 was followed by on intense 
accumulation of inflammatory coils along the intima by days 9-f  ! The tat- 
tar ceils wore mostly mononuclear and displayed markers for macmphagos 
(Mac-l') and T cells (CD4' or CD8*) but not B celts (B220) By day f5. 
there was a virtual replacement el the initial intlammatonj cell response with 
small clusters o1 platolet Ihmmbi along the luminal sudaee. At days 15-21. 
lUXtaluminal platelot thrombi were progressively covered and intiltrated by 
shoots of vascular smooth muscle cells (smooth muscle ,-actin". desmin ° ), 
with incipient accumulation of oxtracellular matrix (Movat's pentachrome). A 
well defined neointima was detected by day 24, with the typical histolog~c 
appearances ot allograft vascular disease The sequence of intimal inflam- 
mation, platelet hrombi, and neointimal oxpans=on was absent in syngene=c 
(h=stocompatible) aortic gratts 
Thus, platelet thmmbi follow inflammatory miury and appear to promote 
subsequent neointimal formation Th=s potent=ally vital but non-=mmuno as- 
pect ot lea=on development has not been trad=honally well recogmzed as a 
part of allogratt vascular disease. 
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1805-21 Estradlol Inhibits A l lograf t  Arteriosclerosis by 
Estrogen Receptor a and ~ Act ivat ion 
S, Saito, H. Lou, P.W. Ramwell. M.L. Foegh. Georgetown University Med~ca! 
Center. Washington PC., USA 
Background: We discovered that inhibition ot transplant artenoscleresis by 
estradiol-171~ rE2) is associated with both down-regulation of MHC class II 
antigen expression and inhibition of macrophage infiltration. These inhibdory 
effects may require estrogen receptor activation in the allograft vessel, we 
treated the recipients with daily inlection ot estradiol ,~ and ,'~ receptor antag- 
onist ZM-182780 ~ZM) 
Method: Orthotopic abdominal aorta altograft transplantation was per- 
formed wdh male Brown-Norway rats as donors and male Lewis rats as re- 
cipients. Recipients {N = 18) were randomly divided into four groups treated 
from day 2 until day 21 posttransplantation with either placebo (vehiclet. 
E2 (20 ~tg/kg'day), ZM (2 mg kgdayL or E2 ÷ ZM. Myointlmal thickening 
(% MT) was measured by morphometry of cross sections ot the allograffs. 
MHC class II antigen expression and macrophage infiltration were graded 
semiquantit ,ve!y on a scale from 0 to +3 following immunohistostaining. 
Results: The effect ot treatment wLth estradiol rE2) and a competitive E2 
receptor antagonist (ZM) on °o MT. MHCtl, Macrophage Infiltration was as 
shown in the table. 
Conclusion: Estradiol inhibition of myointimal thickening. MHC class II 
antigen expression and macrcphage inhltration was reversed by concomi- 
tant administration of a competitive estrogen ,, and 5 receptor antagonist 
suggesting that estrogen receptor actwation inhibits transplant artenosctero- 
sis 
